Edition:
United Kingdom

People: 3D Systems Corp (DDD.N)

DDD.N on New York Stock Exchange

6.87USD
20 Aug 2019
Change (% chg)

$-0.11 (-1.58%)
Prev Close
$6.98
Open
$6.97
Day's High
$6.97
Day's Low
$6.71
Volume
355,348
Avg. Vol
439,874
52-wk High
$21.76
52-wk Low
$6.47

Curran, William 

Mr. William Edward Curran is an a Independent Director of 3D Systems Corporation. Currently retired, Mr. Curran has served as a director of Profound Medical, a public company developing a treatment for prostate cancer using ablative ultrasound and guided by magnetic resonance imaging and thermometry, since 2012. Previously, Mr. Curran served as non-executive Chairman and Director of Resonant Medical, an early-stage privately owned company specializing in three-dimensional ultrasound image-guided adaptive radio therapy products, until May 2010 at which time Resonant was sold to Elekta A.B. He also served until May 2009 as a director of Ventracor, a global medical device company which produced an implantable blood pump, at which time the directors brought in an administrator under Australian law. For more than five years prior to 2004, he held diverse functional and senior management positions with Philips Electronics and Philips Medical Systems. His experience at Philips Medical Systems, a medical device manufacturer, included positions as Chief Operating Officer and Chief Financial Officer, and while at Philips Electronics North America he served as President and Chief Executive Officer as well as Chief Financial Officer.

Basic Compensation

Total Annual Compensation, USD 125,733
Restricted Stock Award, USD 99,998
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 225,731

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles McClure

257,593

Vyomesh Joshi

2,122,620

John McMullen

868,731

Charles Hull

638,417

Herbert Koeck

--

Andrew Johnson

701,445
As Of  31 Dec 2018